Cleveland BioLabs, Inc. (Nasdaq: CBLI) is higher in mid-day action after the company announced that through its research in the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE